CCM
PRCT icon

Cinctive Capital Management’s Procept Biorobotics PRCT Stock Holding History

Cinctive Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-43,583
Closed -$2.51M – 494
2025
Q2 		$2.51M Buy
+43,583
New +$2.46M 0.13% 191

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Cinctive Capital Management's PRCT Position: Q3 2025 in Review

Cinctive Capital Management sold out of Procept Biorobotics (PRCT) in Q3 2025, closing a stake of 43,583 shares — an estimated $2.51M sold.

Cinctive Capital Management first reported a position in PRCT in Q2 2025 and held it in 1 quarter. The position peaked at $2.51M in Q2 2025. 242 funds tracked by Wall St. Rank hold PRCT as of Q3 2025.

  • Cinctive Capital Management reported no remaining Procept Biorobotics position as of Q3 2025 after selling out during the quarter.
  • Cinctive Capital Management sold 43,583 Procept Biorobotics shares in Q3 2025, an estimated $2.51M.
  • Cinctive Capital Management first reported a position in Procept Biorobotics in Q2 2025 and held it in 1 quarter.
  • Cinctive Capital Management's Procept Biorobotics position peaked at $2.51M in Q2 2025.
  • 242 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2025.

Based on Cinctive Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.